Improved outcome of resection of hilar cholangiocarcinoma (Klatskin tumor)

Ann Surg Oncol. 2006 Jun;13(6):872-80. doi: 10.1245/ASO.2006.05.053. Epub 2006 Apr 14.

Abstract

Background: Treatment of hilar cholangiocarcinoma (Klatskin tumors) has changed in many aspects. A more extensive surgical approach, as proposed by Japanese surgeons, has been applied in our center over the last 5 years; it combines hilar resection with partial hepatectomy for most tumors. The aim of this study was to assess the outcome of a 15-year evolution in the surgical treatment of Klatskin tumors.

Methods: A total of 99 consecutive patients underwent resection for hilar cholangiocarcinoma in three 5-year time periods: periods 1 (1988-1993; n=45), 2 (1993-1998; n=25), and 3 (1998-2003; n=29). Outcome was evaluated by assessment of completeness of resection, postoperative morbidity and mortality, and survival.

Results: The proportion of margin negative resections increased significantly from 13% in period 1 to 59% in period 3 (P<.05). Two-year survival increased significantly from 33%+/-7% and 39%+/-10% in periods 1 and 2 to 60%+/-11% in period 3 (P<.05). Postoperative morbidity and mortality were considerable but did not increase with this changed surgical strategy (68% and 10%, respectively, in period 3). Lymph node metastasis was, next to period of resection, also associated with survival in univariate analysis.

Conclusions: Mainly in the last 5-year period (1998-2003), when the Japanese surgical approach was followed, more hilar resections were combined with partial liver resections that included segments 1 and 4, thus leading to more R0 resections. This, together with a decrease in lymph node metastases, resulted in improved survival without significantly affecting postoperative morbidity or mortality.

MeSH terms

  • Adult
  • Aged
  • Bile Duct Neoplasms / surgery*
  • Biliary Tract Surgical Procedures*
  • Cholangiocarcinoma / surgery*
  • Female
  • Follow-Up Studies
  • Hepatectomy
  • Hepatic Duct, Common / surgery*
  • Humans
  • Klatskin Tumor / pathology
  • Klatskin Tumor / surgery*
  • Lymph Nodes / pathology
  • Male
  • Middle Aged
  • Palliative Care
  • Prognosis
  • Survival Rate
  • Treatment Outcome